1. Home
  2. FDA

Tag: FDA

Lupin Q3 Results: CEO On Margins & Regulatory Concerns

Lupin Q3 Results: CEO On Margins & Regulatory Concerns

Lupin Q3 Results: Lupin CEO On Margin Outlook & Regulatory Concerns Lupin Q3 stocks were under pressure yesterday because of the Japanese business investments. The revenues also declined to 4% margin significantly to 11% versus…

Read More
Umang Vohra speaks about cipla Q3 results

Umang Vohra speaks about cipla Q3 results

Umang Vohra speaks about cipla Q3 results Umang Vohra, Cipla MD & CEO speaks about the companies Q3 performance. Stocks: Today’s it companies are up in the front line in stock market. The following IT…

Read More
Translate »